ESC Premium Access

Second-generation drug-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated lesion in the proximal left anterior descending artery

Congress Presentation

About the speaker

Professor Konstantinos Toutouzas

University of Athens, Athens (Greece)
6 presentations
0 follower

26 more presentations in this session

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry

Speaker: Doctor G. Gallone (Turin, IT)


Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction

Speaker: Doctor S. Dani (Ahmedabad, IN)


Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Speaker: Doctor H. Matsuda (Nagoya, JP)


Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

Speaker: Doctor I. Menown (Craigavon, GB)


Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents

Speaker: Miss L. Kerkmeijer (Zwolle, NL)


Access the full session

Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Speakers: Professor K. Toutouzas, Doctor G. Gallone, Doctor S. Dani, Doctor H. Matsuda, Doctor I. Menown...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb